This inventor holds 2 USPTO granted patents. Top assignee: Smithkline Beecham Corporation. Active years: 1997-1998.
Location History:
- Tunbridge Wells, GB (1997)
- Auckland, NZ (1998)
Company Filing History:
Years Active: 1997-1998
Title: The Innovations of Peter William Bickle
Introduction
Peter William Bickle is a notable inventor based in Tunbridge Wells, GB. He has made significant contributions to the field of chemistry, particularly in the development of intermediates for medicinal applications. With a total of 2 patents, Bickle's work has the potential to impact the treatment of various medical conditions.
Latest Patents
Bickle's latest patents include innovations related to certain 3-hydroxy-6-hydroxymethyl-pyridine intermediates. One of his key inventions involves palladium-catalyzed vinylic substitution reactions. This invention describes a coupling reaction that utilizes an organo-metallic catalyst, preferably palladium. The process involves reacting 2-halo-3-hydroxy-6-hydroxymethylpyridine with acrylic acid or its alkali metal salt and a benzyl or phenylalkyl derivative in the presence of a dipolar aprotic solvent. The expected outcome is the production of 2-propenoate-3-benzyl or phenylalkylether-6-hydroxymethyl-pyridine products. These products are then converted into medicaments that are useful for treating psoriasis.
Career Highlights
Bickle is currently associated with SmithKline Beecham Corporation, where he continues to innovate and develop new chemical processes. His work has been instrumental in advancing the field of medicinal chemistry.
Collaborations
Throughout his career, Bickle has collaborated with notable colleagues, including Peter William Sheldrake and Laurence Charles Powling. These collaborations have contributed to the success of his projects and the advancement of their shared goals in research and development.
Conclusion
Peter William Bickle's contributions to the field of chemistry and his innovative patents demonstrate his commitment to improving medical treatments. His work continues to pave the way for advancements in the pharmaceutical industry.